Identification of prognostic factors in patients with diffuse large B-cell lymphoma

Fang Peng1, Liang Guo1, Wei-Kai Yao1

  • 1Department of Pathology, The First Hospital of Jilin University, Changchun, China.

Insights

Prognostic factors like ECOG performance score and specific protein expressions (Bcl-2, CD10, Bcl-6) predict outcomes in diffuse large B-cell lymphoma (DLBCL). These factors remain significant even in cases with conflicting classifications.

Area of Science:

  • Hematology
  • Oncology
  • Immunohistochemistry

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease.
  • Prognostic classification algorithms like Hans' and Choi's aid in predicting patient outcomes.
  • Conflicting classifications between algorithms can complicate prognostic assessment.

Purpose of the Study:

  • To identify prognostic factors for de novo diffuse large B-cell lymphoma (DLBCL) patients.
  • To evaluate prognostic factors in DLBCL cases with conflicting classifications by Hans' and Choi's algorithms.
  • To assess the concordance and clinical relevance of two major DLBCL classification algorithms.

Main Methods:

  • Retrospective review of clinical and pathological data from 154 de novo DLBCL patients.
  • Classification of DLBCL subtypes using Hans' and Choi's algorithms with immunohistochemical markers.
  • Statistical analysis of clinicopathological factors, International Prognostic Index, and 5-year survival rates.

Main Results:

  • Eastern Cooperative Oncology Group (ECOG) performance score 2-5, positive Bcl-2, negative CD10, and negative Bcl-6 expression correlated with worse prognosis.
  • Hans' and Choi's algorithms showed good concordance (83% agreement, Kappa = 0.660).
  • Germinal center B-cell-like (GCB) subtype had significantly better 5-year overall survival than non-GCB subtypes by both classifications.
  • In the 25 cases with conflicting classifications, the same adverse prognostic factors (ECOG 2-5, positive Bcl-2, negative CD10, negative Bcl-6) were identified.

Conclusions:

  • ECOG performance score 2-5, positive Bcl-2, negative CD10, and negative Bcl-6 expression are independent markers for poor prognosis in DLBCL.
  • These prognostic markers retain significance even in DLBCL cases with conflicting classifications between Hans' and Choi's algorithms.
  • The study highlights key immunohistochemical markers for predicting DLBCL patient outcomes, irrespective of classification algorithm discrepancies.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
312
Diffusion01:12

Diffusion

Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
217.2K
Diffusion01:21

Diffusion

Diffusion is a type of passive transport. In passive transport, a substance tends to move from an area of high concentration to an area of low concentration until the concentration is equal across the space. For example, take the diffusion of substances through the air. When someone opens a perfume bottle in a room filled with people, the perfume is at its highest concentration in the bottle and is at its lowest at the edges of the room. The perfume vapor will diffuse, or spread away, from the...
6.3K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Facilitated Diffusion01:16

Facilitated Diffusion

The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.2K